Cormorant Asset Management, LP

Holdings History for MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)

Symbol: MLTX on Nasdaq
Investment type: Equity / Class A ordinary share, par value $0.0001 per share
Latest Disclosed Shares Owned: 4,355,433 shares
Security Ownership %: 6.1%

Shares, Excluding Options vs Price

Value, Excluding Options

Cormorant Asset Management, LP ownership in MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX)

17 Feb 2026 - Cormorant Asset Management, LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,355,433 shares of MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX). This represents 6.1% ownership of the company. This is the first filing by Cormorant Asset Management, LP disclosing ownership of MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Cormorant Asset Management, LP	6.1%		$74,477,904	4,355,433			$17.10	13G	31 Dec 2025	17 Feb 2026, 15:01

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	3.3%	+1.8%	$57,404,607	4,355,433	+2,361,260	+118%	$13.18	Q4 2025
30 Sep 2025	0.99%	-3.2%	$14,298,220	1,994,173	-6,499,978	-77%	$7.17	Q3 2025
30 Jun 2025	30%	0%	$400,923,927	8,494,151	0		$47.20	Q2 2025
31 Mar 2025	25%	0%	$331,866,480	8,494,151	0		$39.07	Q1 2025
31 Dec 2024	25%	0%	$459,958,277	8,494,151	0		$54.15	Q4 2024
30 Sep 2024	23%	0%	$428,275,093	8,494,151	0		$50.42	Q3 2024
30 Jun 2024	22%	0%	$373,487,819	8,494,151	0		$43.97	Q2 2024
31 Mar 2024	19%	0%	$426,661,205	8,494,151	0		$50.23	Q1 2024
31 Dec 2023	25%	+1%	$512,961,779	8,494,151	+352,051	+4.3%	$60.39	Q4 2023
30 Sep 2023	27%	0%	$464,099,700	8,142,100	0		$57.00	Q3 2023
30 Jun 2023	24%	+3.6%	$415,247,100	8,142,100	+1,249,999	+18%	$51.00	Q2 2023
31 Mar 2023	9.7%	+1.2%	$147,422,000	6,892,101	+827,100	+14%	$21.39	Q1 2023
31 Dec 2022	4.3%	0%	$63,683,000	6,065,001	0		$10.50	Q4 2022
30 Sep 2022	3.3%	0%	$47,064,000	6,065,001	0		$7.76	Q3 2022
30 Jun 2022	2.4%	+2.4%	$30,886,000	6,065,001	+6,065,001	NEW	$5.09	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.